These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31280699)

  • 1. An IQ Consortium Perspective on The Scientific Committee on Health, Environmental and Emerging Risks Final Opinion on the Need for Nonhuman Primates in Biomedical Research, Production and Testing of Products and Devices (Update 2017).
    Adams K; Clemons D; Impelluso LC; Lee D; Maguire S; Myers A; Petursson C; Schulingkamp R; Trouba K; Wright M
    Toxicol Pathol; 2019 Jul; 47(5):649-655. PubMed ID: 31280699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SCHER report on non-human primate research - biased and deeply flawed.
    Bailey J; Taylor K
    Altern Lab Anim; 2009 Sep; 37(4):427-35. PubMed ID: 19807214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying the 3Rs to neuroscience research involving nonhuman primates.
    Lemon RN
    Drug Discov Today; 2018 Sep; 23(9):1574-1577. PubMed ID: 29733893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The great primate debate.
    Goodman S; Check E
    Nature; 2002 Jun; 417(6890):684-7. PubMed ID: 12066153
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress.
    Zhang XL; Pang W; Hu XT; Li JL; Yao YG; Zheng YT
    Dongwuxue Yanjiu; 2014 Nov; 35(6):447-64. PubMed ID: 25465081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the Reuse of Protein Non-Naïve Nonhuman Primates in Pharmaceutical Drug Discovery and Development: An Overview and Industry Position on the Challenges and Benefits.
    Mattis C; Bratcher N; Burns M; Carosino C; de Zafra C; Fancher RM; Georgi K; Graff C; Hukkanen RR; Johnson C; Lao Y; Lange A; Lee D; Lepherd M; Maguire S; Malisauskas M; Manuel M; Miranda S; Reed L; Santos R; Sayers B; Shaw D; Shuster D
    Int J Toxicol; 2022 Aug; 41(4):291-296. PubMed ID: 35656559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of animals in research will never be possible.
    Caminiti R
    Nature; 2009 Jan; 457(7226):147. PubMed ID: 19129827
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-Human Primate Husbandry and Impact on Non-Human Primates Health: Outcomes From an IQ DruSafe/3RS Industrial Benchmark Survey.
    Salian-Mehta S; Poling J; Birkebak J; Rensing S; Carosino C; Santos R; West W; Adams K; Orsted K; Fillman-Holliday D; Burns M
    Int J Toxicol; 2023; 42(2):111-121. PubMed ID: 36543758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry: Results of an IQ DruSafe Minipig Survey.
    Colleton C; Brewster D; Chester A; Clarke DO; Heining P; Olaharski A; Graziano M
    Toxicol Pathol; 2016 Apr; 44(3):458-66. PubMed ID: 27006130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balancing the welfare: the use of non-human primates in research.
    Zhou Q
    Trends Genet; 2014 Nov; 30(11):476-8. PubMed ID: 25438695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals.
    van Meer PJ; Graham ML; Schuurman HJ
    Eur J Pharmacol; 2015 Jul; 759():3-13. PubMed ID: 25818943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advice to the European Commission as Regards Type and Criteria for Comprehensive Studies to Be Requested From Manufacturers: The Opinion of the Scientific Committee on Health, Environmental, and Emerging Risks (SCHEER).
    Talhout R; Duarte-Davidson R; Hoet P; Nair U; Rydzynski K; Vermeire T; Zacharov S; Testai E
    Nicotine Tob Res; 2020 Apr; 22(5):613-618. PubMed ID: 31329942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
    Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
    Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caring for nonhuman primates in biomedical research facilities: scientific, moral and emotional considerations.
    Coleman K
    Am J Primatol; 2011 Mar; 73(3):220-5. PubMed ID: 20575044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European experimental animal use declines ever so slightly.
    Hudson M; Balls M
    Altern Lab Anim; 2010 Dec; 38(6):529-32. PubMed ID: 21275474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving rigor and reproducibility in nonhuman primate research.
    Bliss-Moreau E; Amara RR; Buffalo EA; Colman RJ; Embers ME; Morrison JH; Quillen EE; Sacha JB; Roberts CT;
    Am J Primatol; 2021 Dec; 83(12):e23331. PubMed ID: 34541703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ethics of Infection Challenges in Primates.
    Barnhill A; Joffe S; Miller FG
    Hastings Cent Rep; 2016 Jul; 46(4):20-6. PubMed ID: 27417865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International primate neuroscience research regulation, public engagement and transparency opportunities.
    Mitchell AS; Hartig R; Basso MA; Jarrett W; Kastner S; Poirier C
    Neuroimage; 2021 Apr; 229():117700. PubMed ID: 33418072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FRAME Reduction Steering Committee: reflections on a decade devoted to reducing animal use in biomedical science.
    Hudson M; Howard B
    Altern Lab Anim; 2009 Feb; 37(1):23-6. PubMed ID: 19292572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting the implementation of the Three Rs in European primate and mouse research papers: are we making progress?
    Taylor K
    Altern Lab Anim; 2010 Dec; 38(6):495-517. PubMed ID: 21275472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.